What is Zappy?
Zappy is an enterprise focused on the transformative potential of psychedelic medicine, driven by a core belief in its capacity to rapidly elevate human consciousness and redirect societal trajectories away from destructive paths. The company's mission is to enhance the accessibility of psychedelic compounds through a multi-faceted approach encompassing education, media dissemination, scientific research, clinical development, and commercial ventures. This strategic focus positions Zappy at the forefront of a rapidly evolving industry.
How much funding has Zappy raised?
Zappy has raised a total of $692K across 1 funding round:
Private Equity
$692K
Private Equity (2014): $692K, investors not publicly disclosed
What's next for Zappy?
The recent major strategic investment and the overall enterprise-level funding context suggest Zappy is poised for significant scaling and expansion. This capital infusion will likely fuel further research and development initiatives, potentially accelerating clinical trials and broadening the company's educational outreach. Zappy's commitment to increasing accessibility indicates a strategic roadmap focused on market penetration and establishing a robust presence within the psychedelic therapeutics and consciousness exploration sectors.
See full Zappy company page
